Funding Opportunity RFA-DA-24-002 from the NIH Guide for Grants and Contracts. This broad PAR will support exploratory studies addressing mechanistic questions in HIV infection, replication, latency, and/or pathogenesis (including HAND) in the context of SUDs.

Notice NOT-HS-23-002 from the NIH Guide for Grants and Contracts

Notice NOT-OD-23-019 from the NIH Guide for Grants and Contracts

Notice NOT-GM-23-020 from the NIH Guide for Grants and Contracts

Notice NOT-CA-23-013 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-041 from the NIH Guide for Grants and Contracts

Notice NOT-DA-24-002 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-AI-22-069 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) seeks to solicit applications from interdisciplinary teams to participate in the Cooperative Centers on Human Immunology (CCHI) program. The program supports mechanistic and hypothesis-testing studies to discover novel molecules, mechanisms, or regulatory pathways governing function of the human immune system in both healthy and vulnerable populations (i.e., across lifespan, organ/tissue transplant recipients, pregnant women). Studies of interest include immunity related to prevention or treatment of infectious diseases, immune-mediated pathogenesis/sequelae associated with infectious disease, and/or immune-mediated diseases. This FOA also supports technology development to advance studies of the human immune system. The overarching goal of the CCHI is to provide foundational information on human immune system function to support translation of immunology research into clinical benefits.

Notice NOT-MH-23-135 from the NIH Guide for Grants and Contracts

Notice NOT-MH-23-136 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-23-047 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states.

Funding Opportunity PAR-23-046 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) encourages research grant applications directed toward developing next-generation human cell-derived microphysiological systems (MPS) and related assays that replicate complex nervous system architectures and physiology with improved fidelity over current capabilities. Supported projects will be expected to enable future studies of complex nervous system development, function and aging in healthy and disease states.

Notice NOT-DA-22-065 from the NIH Guide for Grants and Contracts

Notice NOT-HL-22-052 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-039 from the NIH Guide for Grants and Contracts

Notice NOT-NS-23-040 from the NIH Guide for Grants and Contracts

Notice NOT-HD-22-054 from the NIH Guide for Grants and Contracts

Funding Opportunity RFA-OD-22-026 from the NIH Guide for Grants and Contracts. The purpose of the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00) is to increase and maintain a strong cohort of new and talented independent investigators conducting research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions

Funding Opportunity RFA-OD-22-025 from the NIH Guide for Grants and Contracts. The purpose of the Pathway to Independence Award in Tobacco Regulatory Research (K99/R00) is to increase and maintain a strong cohort of new and talented independent investigators conducting research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing. This program is designed to facilitate a timely transition of outstanding postdoctoral researchers with a research and/or clinical doctorate degree from mentored, postdoctoral research positions to independent, tenure-track or equivalent faculty positions

Funding Opportunity RFA-OD-22-024 from the NIH Guide for Grants and Contracts. The purpose of the Mentored Research Scientist Career Development Award in Tobacco Regulatory Research (K01) is to provide support and protected time (three, four, or five years) for an intensive, supervised career development experience in biomedical, behavioral, and social science research that will inform the development and evaluation of regulations on tobacco product manufacturing, distribution, and marketing and that will lead to research independence. Research projects must address the research priorities related to the regulatory authority of the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) as mandated by the Family Smoking Prevention and Tobacco Control Act (FSPTCA), Public Law 111-31.